BamSEC and AlphaSense Join Forces
Learn More

PTC Therapeutics Inc.

NASDAQ: PTCT    
Share price (12/23/24): $45.56    
Market cap (12/23/24): $3.514 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.4
from S-3ASR 7 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 7 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 48 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 44 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 107 pages PTC Therapeutics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of September 20, 2019 1.50% Convertible Senior Notes Due 2026
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 55 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 52 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 112 pages PTC Therapeutics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of August 14, 2015 3.00% Convertible Senior Notes Due 2022
12/34/56
EX-4.4
from S-3ASR 7 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 7 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 43 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities Cross-Refrence Table
12/34/56
EX-4.1
from S-3ASR 40 pages PTC Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.2
from S-1 29 pages PTC Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement Dated as of March 7, 2013
12/34/56
EX-4.1
from S-1 1 page Indenture or similar
12/34/56
EX-4.2
from DRS 29 pages PTC Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement Dated as of March 7, 2013
12/34/56
EX-4.10
from S-1 ~10 pages Ex-4.10: Warrant
12/34/56